JPWO2023286836A1 - - Google Patents

Info

Publication number
JPWO2023286836A1
JPWO2023286836A1 JP2023534857A JP2023534857A JPWO2023286836A1 JP WO2023286836 A1 JPWO2023286836 A1 JP WO2023286836A1 JP 2023534857 A JP2023534857 A JP 2023534857A JP 2023534857 A JP2023534857 A JP 2023534857A JP WO2023286836 A1 JPWO2023286836 A1 JP WO2023286836A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534857A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023286836A1 publication Critical patent/JPWO2023286836A1/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20—Sequence assembly

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Medicinal Preparation (AREA)
JP2023534857A 2021-07-16 2022-07-14 Pending JPWO2023286836A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021117807 2021-07-16
PCT/JP2022/027709 WO2023286836A1 (fr) 2021-07-16 2022-07-14 Conjugué d'acide nucléique artificiel

Publications (1)

Publication Number Publication Date
JPWO2023286836A1 true JPWO2023286836A1 (fr) 2023-01-19

Family

ID=84920282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534857A Pending JPWO2023286836A1 (fr) 2021-07-16 2022-07-14

Country Status (2)

Country Link
JP (1) JPWO2023286836A1 (fr)
WO (1) WO2023286836A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012165672A (ja) * 2011-02-10 2012-09-06 Tottori Univ １塩基認識能を増幅する人工核酸コンジュゲート
US9683237B2 (en) * 2014-04-25 2017-06-20 Strike Bio, Inc. Multiple targeted RNAI for the treatment of cancers
CN114502202A (zh) * 2019-07-24 2022-05-13 纽约市哥伦比亚大学理事会 用于通过使用基于肽核酸的试剂来治疗癌症的方法和组合物
CN114641570A (zh) * 2019-08-14 2022-06-17 科迪亚克生物科学公司 具有靶向kras的反义寡核苷酸的细胞外囊泡

Also Published As

Publication number Publication date
WO2023286836A1 (fr) 2023-01-19

Similar Documents

Publication Publication Date Title
BR112023012656A2 (fr)
BR102021018859A2 (fr)
BR102021007058A2 (fr)
BR102020022030A2 (fr)
JPWO2023286836A1 (fr)
BR112023011738A2 (fr)
BR112023016292A2 (fr)
BR102021020147A2 (fr)
BR102021018926A2 (fr)
BR102021018167A2 (fr)
BR102021017576A2 (fr)
BR102021016837A2 (fr)
BR102021016551A2 (fr)
BR102021016375A2 (fr)
BR102021016200A2 (fr)
BR102021016176A2 (fr)
BR102021015566A2 (fr)
BR102021013929A2 (fr)
BR102021012571A2 (fr)
BR102021012230A2 (fr)
BR102021012107A2 (fr)
BR102021012003A2 (fr)
BR112021013417A2 (fr)
BR102021010467A2 (fr)
BR102021009555A2 (fr)

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20240807